GPAT2 is a 795-amino-acid protein with a molecular weight of 87.8 kDa, localized to the mitochondrial outer membrane . Key features include:
GPAT2 belongs to the GPAT/DAPAT protein family and catalyzes the acylation of glycerol-3-phosphate using arachidonoyl-CoA as a preferred substrate, contributing to triacylglycerol (TAG) synthesis and membrane lipid composition .
GPAT2 Antibody is utilized in diverse experimental approaches to study GPAT2 expression and function. Below are key applications and technical specifications:
Immunofluorescence (IF): Visualizing mitochondrial GPAT2 localization .
Western Blot (WB): Quantifying GPAT2 protein levels in cell lysates .
Immunohistochemistry (IHC): Detecting GPAT2 in tumor tissues (e.g., breast, prostate cancers) .
Immunocytochemistry (ICC): Analyzing subcellular distribution in cultured cells .
GPAT2 Antibody has enabled critical discoveries in cancer biology, lipid metabolism, and germ cell development.
GPAT2 is classified as a cancer-testis antigen, overexpressed in aggressive tumors (e.g., breast, lung, melanoma) while restricted to testis under physiological conditions . Key findings:
Tumor Proliferation: GPAT2 knockdown in MDA-MB-231 breast cancer cells reduced proliferation (50% decrease) and migration (30% reduction) .
Apoptosis Resistance: Overexpression increased resistance to staurosporine-induced apoptosis (2-fold survival) .
Histological Correlation: High GPAT2 expression in breast cancer correlated with advanced histological grades .
GPAT2 modulates lipid composition, influencing cell membrane properties:
Arachidonic Acid (AA) Sequestration: GPAT2 channels AA into TAGs, preventing apoptosis in spermatogenic cells .
Membrane Roughness: GPAT2-expressing cells exhibit rougher topography and reduced membrane permeability compared to silenced cells .
GPAT2 associates with piRNA metabolism in germ cells, though its acyltransferase activity is not directly involved . Co-expression analysis in testis linked GPAT2 to:
GPAT2 expression is silenced in somatic tissues and reactivated in cancers via DNA hypomethylation. Treatment with 5-Aza-2′-deoxycytidine induced GPAT2 expression in human cell lines, confirming epigenetic control .
Antibody Specificity: Cross-reactivity with other GPAT isoforms (e.g., GPAT1) must be validated, particularly in mitochondrial studies .
Compensation Mechanisms: AGPAT11 overexpression may compensate for GPAT2 loss in lipid metabolism .
GPAT2’s role in tumor survival and lipid remodeling positions it as a potential therapeutic target: